CardioGenics Holdings Inc (CGNH)

CardioGenics Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Jan 31, 2016	Oct 31, 2015	Oct 31, 2014	Oct 31, 2013	Oct 31, 2012	Oct 31, 2011
Net Income	-0.98	-1.92	-2.68	-2.92	-1.31	-5.72
Depreciation & Amortization	0.01	0.01	0.02	0.02	0.03	0.03
Other Amortization	-	-	0.62	0.11	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	0.02	0.06
Stock-Based Compensation	0	0	0.1	1.39	-	2.33
Other Operating Activities	0.32	1.06	1.1	0.2	-0.01	1.62
Change in Accounts Receivable	0	0	0	0	0.01	-0.01
Change in Accounts Payable	0.28	0.22	0.18	0.42	0.19	0.07
Change in Income Taxes	-0	0	0	0.04	-0.01	-0.01
Change in Other Net Operating Assets	-0	0	0.06	0.02	0.11	0.12
Operating Cash Flow	-0.37	-0.61	-0.6	-0.72	-0.97	-1.52
Capital Expenditures	-	-	-	-0	-0	-0.02
Sale (Purchase) of Intangibles	-0	-0	-	-0.02	-0	-0.02
Investing Cash Flow	-0.29	-0	-	-0.02	-0.01	-0.03
Short-Term Debt Issued	-	0.33	0.35	0.14	0.1	-
Long-Term Debt Issued	-	-	-	0.7	-	-
Total Debt Issued	0.56	0.33	0.35	0.84	0.1	-
Short-Term Debt Repaid	-	-0	-	-	-	-0.02
Long-Term Debt Repaid	-	-	-	-0	-0.03	-0.01
Total Debt Repaid	-0.01	-0	-	-0	-0.03	-0.03
Net Debt Issued (Repaid)	0.55	0.32	0.35	0.83	0.07	-0.03
Issuance of Common Stock	0.05	0.04	0.05	0.1	0.26	0.36
Other Financing Activities	-	-	-	-	-	-0.02
Financing Cash Flow	0.6	0.36	0.4	0.93	0.34	0.32
Foreign Exchange Rate Adjustments	0.07	0.22	0.01	0.04	-0	0.06
Net Cash Flow	0.01	-0.02	-0.19	0.24	-0.64	-1.18
Free Cash Flow	-0.37	-0.61	-0.6	-0.72	-0.97	-1.54
Free Cash Flow Margin	-	-	-	-	-75147.49%	-17307.17%
Free Cash Flow Per Share	-0.00	-0.01	-0.01	-0.01	-0.02	-0.03
Cash Interest Paid	0.02	0.02	0.02	0.03	0.02	0.02
Levered Free Cash Flow	-0.66	-0.4	-0.89	0.29	-0.51	1.7
Unlevered Free Cash Flow	-0.39	-0.1	-0.35	0.36	-0.49	1.71
Change in Working Capital	0.28	0.23	0.25	0.48	0.3	0.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.